Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with locally advanced or metastatic (stage Ill or IV) non-small cell lung cancer (NSCLC)
Relapsed disease following, or unable to tolerate, at least one line of prior chemotherapy
Initiated on single-agent docetaxel up to a maximum of 6 years prior to date of collection
Aged 18 years at date of first docetaxel dose
Completed or stopped treatment with docetaxel at least 30 days prior to date of data collection
You may not be if
Receiving docetaxel in an interventional clinical trial
For whom no details of absolute neutrophil count are recorded
Clareo Health | Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK
